| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |